Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells Article (Faculty180)

authors

published in

volume

  • BMC Cancer. (2019) Nov 11;19(1):1081. https://doi:10.1186/s12885-019-6313-x PMID: 31711466